Editorial: Health benefits of flavonoids in diabetes and obesity: from experimental approaches to clinical use

Ali Chaari; Dietrich Büsselberg; Nabil Miled

doi:10.3389/fnut.2023.1312635

Editorial: Health benefits of flavonoids in diabetes and obesity: from experimental approaches to clinical use

Front Nutr. 2023 Oct 30:10:1312635. doi: 10.3389/fnut.2023.1312635. eCollection 2023.

Authors

Ali Chaari¹, Dietrich Büsselberg¹, Nabil Miled²

Affiliations

¹ Weill Cornell Medicine-Qatar, Qatar Foundation, Doha, Qatar.
² College of Science, University of Jeddah, Jeddah, Saudi Arabia.

No abstract available

Keywords: diabetes; obesity; polyphenols; prevention medicine; therapy.

Publication types

Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by a National Priorities Research Program grant (NPRP 14S-0311-210033; awarded to DB, January 2023-Current) from the Qatar National Research Fund (QNRF, a member of Qatar Foundation). The statements made herein are solely the responsibility of the authors.